The White House has reportedly signed off on a plan to fire U.S. FDA Commissioner Marty Makary, signaling a potential leadership shake-up at the federal health agency. Sources say the White House is considering naming FDA Deputy Commissioner Kyle Diamantas, who oversees the agency’s food division, as acting commissioner. The move follows heightened fallout tied to controversial drug, abortion, and vape issues.
Drugmaker Granules says it will tighten internal oversight following a warning from the US FDA. The company, one of the world’s biggest paracetamol makers and a key active pharmaceutical ingredients player, earns a large share of revenue from the United States—making compliance scrutiny especially consequential for future supply and sales.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Granules India says it will strengthen its manufacturing oversight after a US FDA warning related to documentation practices and contamination concerns. The company plans to digitize workflows and automate record management to improve data accuracy and compliance. Granules is positioning the reforms as proactive steps to address regulatory pressure while maintaining product quality across its facilities.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
